How Long Can You Live with Untreated Sleep Apnea?
Severe untreated sleep apnea doubles all-cause mortality risk. Here is what large-scale studies reveal about life expectancy — and how treatment returns it to normal.
Reviewed by Dr. Christopher Henninger, DMD
Last updated February 2026
Key Takeaways
- Severe untreated obstructive sleep apnea carries a 2.1x higher all-cause mortality risk and 2.7x higher cardiovascular mortality risk compared to controls.
- The risk is dose-dependent: mild OSA shows modest increases, but severe OSA more than doubles mortality — and severity can worsen over time without treatment.
- Treatment effectively restores life expectancy to near-normal. Patients who use CPAP or oral appliance therapy consistently have mortality rates comparable to people without sleep apnea.
What the Research Says About Mortality
This is the question nobody wants to ask — but if you have been diagnosed with sleep apnea and are wondering whether it really matters, the answer is in the data. Large-scale studies following thousands of patients over decades have established a clear connection between untreated obstructive sleep apnea and shortened life expectancy.
The relationship is dose-dependent: the more severe your sleep apnea and the longer it goes untreated, the greater the impact on mortality. But the data also shows something important — treatment dramatically reduces that risk, returning life expectancy toward normal.
2.1x
all-cause mortality risk in severe untreated OSA
2.7x
cardiovascular mortality risk in severe untreated OSA
Near-normal
life expectancy with consistent treatment
A meta-analysis pooling 27 cohort studies with over 3 million participants found that severe untreated OSA carries a hazard ratio of 2.13 for all-cause mortality — meaning these patients are more than twice as likely to die during any given follow-up period compared to controls. Cardiovascular mortality specifically showed a hazard ratio of 2.73 in severe cases.
Severity Matters: Mild vs. Moderate vs. Severe
Not all sleep apnea carries the same mortality risk. Your AHI (apnea-hypopnea index) score — the number of breathing interruptions per hour of sleep — determines severity, and severity determines how urgently treatment is needed.
| Severity | AHI Score | All-Cause Mortality Risk | CV Mortality Risk |
|---|---|---|---|
| Mild | 5-14 events/hr | 1.2x baseline | 1.2x baseline |
| Moderate | 15-29 events/hr | 1.3x baseline | 2.1x baseline |
| Severe | 30+ events/hr | 2.1x baseline | 2.7x baseline |
Notice the sharp jump from moderate to severe. While mild and moderate OSA carry meaningful but modest increases in mortality, severe OSA more than doubles your risk. This is why sleep medicine specialists emphasize treatment for moderate-to-severe cases — though even mild sleep apnea warrants monitoring and symptom management.
Severity can change over time
Sleep apnea is progressive. Mild OSA can become moderate or severe over years, especially with weight gain, aging, or hormonal changes. A sleep test result from 5 years ago may no longer reflect your current severity. If symptoms have worsened, retesting is recommended.
How Age Affects the Risk
Age interacts with untreated sleep apnea in two important ways. First, sleep apnea becomes more common with age — prevalence roughly doubles between age 40 and age 65. Second, the cardiovascular and metabolic consequences of untreated OSA compound over time, meaning that decades of untreated disease create exponentially greater risk than years.
Adults under 50
Untreated sleep apnea in younger adults is associated with the sharpest relative increase in cardiovascular mortality. The nightly stress response accelerates damage to blood vessels and heart tissue during a period when these conditions would not normally develop.
Adults 50-65
This age group carries the highest absolute risk because sleep apnea compounds existing age-related cardiovascular changes. Hypertension, metabolic syndrome, and cardiac arrhythmias become significantly more common and more difficult to control.
Adults over 65
In older adults, untreated OSA is increasingly linked to cognitive decline, dementia risk, and falls related to daytime drowsiness. The relationship between OSA and all-cause mortality remains significant even in this age group, though other health factors also contribute.
Regardless of age, the principle is the same: the longer sleep apnea goes untreated, the more cumulative damage occurs. A 40-year-old with untreated moderate OSA who waits 10 years to seek treatment has absorbed a decade of nightly cardiovascular stress, metabolic disruption, and cognitive strain that could have been prevented.
Leading Causes of Death in Untreated OSA
Untreated sleep apnea rarely causes death directly from airway obstruction during sleep. Instead, it kills through the chronic damage it inflicts on the cardiovascular, cerebrovascular, and metabolic systems. Understanding these pathways helps explain why treatment is so effective — and why waiting is so costly.
Primary Mortality Pathways
Heart attack, sudden cardiac arrest, and heart failure — driven by chronic hypertension, arrhythmias, and accelerated atherosclerosis.
Both ischemic and hemorrhagic stroke risk increase significantly. The oxygen desaturation and blood pressure swings promote clot formation and vessel damage.
Drowsy driving from unrefreshing sleep is comparable to impaired driving. Fatal accidents are disproportionately common among untreated OSA patients.
Type 2 diabetes and its complications, driven by insulin resistance and chronic inflammation from sleep fragmentation.
Research also suggests an emerging link between untreated OSA and cancer mortality, likely through chronic hypoxia promoting tumor angiogenesis. While this research is still developing, it adds another dimension to the case for treatment. For a comprehensive look at how these risks develop, see our detailed guide on what happens when sleep apnea goes untreated.
Treatment Restores Life Expectancy
Here is the most important data point in this entire article: treatment works. Studies consistently show that patients who treat their sleep apnea — and use treatment consistently — have mortality rates comparable to people without sleep apnea.
Without Treatment
With Consistent Treatment
The key word is consistent. Treatment only works when it is used. This is the critical limitation of CPAP — while it is highly effective in laboratory settings, 30-50% of users abandon it within the first year, and many who continue do not use it enough hours per night to get the full protective benefit.
This is why oral appliance therapy achieves comparable real-world cardiovascular protection for many patients — because the treatment used 7 hours per night, 7 nights per week provides more cumulative benefit than a treatment used 4 hours per night, 4 nights per week.
Taking Action Today
If you have sleep apnea — or suspect you might — the data makes one thing clear: waiting costs you. Every year of untreated sleep apnea adds to the cumulative cardiovascular stress, metabolic disruption, and cognitive strain that reduce both lifespan and quality of life.
Do
Don't
The most powerful finding in sleep apnea research is not how dangerous the condition is — it is how effectively treatment erases that danger. Patients who recognize the symptoms early and begin treatment promptly have the best long-term outcomes.
Not sure where to start? Take our free 2-minute sleep assessment to understand your risk level, or learn about what to expect from a home sleep test. The path from diagnosis to treatment is shorter and simpler than most people expect.
Frequently Asked Questions
Can untreated sleep apnea shorten your life?
Yes. Large-scale studies show that severe untreated obstructive sleep apnea carries a 2.1x higher all-cause mortality risk and 2.7x higher cardiovascular mortality risk. The primary causes of death are cardiovascular events (heart attack, sudden cardiac arrest), stroke, and motor vehicle accidents related to daytime drowsiness.
How many years does sleep apnea take off your life?
While individual outcomes vary, research indicates that severe untreated OSA is associated with significantly reduced life expectancy, primarily through accelerated cardiovascular disease. The exact number of years depends on severity, age, and other health factors — but consistent treatment returns life expectancy toward normal baseline.
Does treating sleep apnea improve life expectancy?
Yes. Studies consistently show that patients who treat their sleep apnea with CPAP or oral appliance therapy and use treatment consistently have mortality rates comparable to people without sleep apnea. The key is consistent use — a treatment used every night provides far more protection than one used intermittently.
Is mild sleep apnea dangerous?
Mild sleep apnea carries a modest mortality increase (about 1.2x baseline) but should not be ignored. Sleep apnea is progressive — mild cases can worsen to moderate or severe over time due to aging, weight gain, and hormonal changes. Monitoring and symptom management are recommended even for mild cases.